Abstract:Pancreatic ductal adenocarcinoma (PDAC) is the 4th leading cause of cancer-related death with a five-year survival rate of 10%. Dense desmoplasia results in poor intratumoral perfusion and elevated interstitial fluid pressure, creating regions with severe oxygen and nutrient deprivation. One result is a deficiency in unsaturated fatty acids (uFAs), as the de novo synthesis of uFAs requires oxygen. Our results indicate that PDAC cells experience endoplasmic reticulum (ER) stress and trigger subsequent ER stress responses under uFA limited conditions in vitro. ER stress responses are governed by three major stress sensors: Inositol-requiring enzyme 1α (IRE1α), PKR-like ER kinase (PERK) and activating transcription factor 6 (ATF6). ER stress responses are also activated in PDAC murine and patient samples. Interestingly, the expression of ER stress markers is much higher in malignant lesions than benign pancreatic intraepithelial neoplasia. In contrast to tumor promoting, we found that PERK, ATF6 and IRE1α - XBP1 are cytotoxic to PDAC cells in vitro, as their knockout improved viability under stress conditions. Surprisingly, pharmacological inhibitor of XBP1 splicing, B-I09, didn't recapitulate the results of the genetic approach. While B-I09 has cytoprotective effects in some PDAC lines, it is cytotoxic in others. In addition to inhibiting XBP1 splicing, B-I09 also inhibits regulated IRE1α dependent decay (RIDD). We speculate that RIDD might have opposite roles to XBP1s, leading to the discrepancy in the cellular phenotypes we observed. Most B-I09 responders are reported to be the basal-like transcriptional subtype. Therefore, we hypothesize that the basal-like subtype is more susceptible to B-I09. So far, we have shown that basal-like patient tumors are significantly enriched in the ER stress response pathways from bulk patient RNA-seq datasets, and we are currently validating this result in the publicly available scRNA-seq datasets from patients which contain basal-like and classical subtypes. We have generated isogenic models with basal-like features, such as epithelial to mesenchymal transition and deltaNP63 overexpression. However, our results suggest that these basal-like features did not sensitize classical PDAC cells to B-I09. Our lab has previously shown that B-I09 is selectively lethal to the MYC-transformed tumors. We are currently testing whether MYC overexpression would sensitize the non-responders to B-I09. It is exciting to see that some of the PDAC lines such as PANC1 and KPC murine line 4662 have reduced viability under B-I09 treatment. However, in our subcutaneous xenograft and allograft experiments, B-I09 only leads to a mild tumor growth suppression, which is unlikely to be therapeutically beneficial by itself. We are currently testing whether XBP1 inhibition could result in an enhanced tumor suppression using OVA antigen stimulated system, as XBP1 inhibition in tumor cells was shown to have tumor-repressing roles via immune system. Citation Format: Yanqing (Christine) Jiang, Xu Han, Nathan Coffey, Mai Wang, John Tobias, Raymond Ng, Carson Poltorack, M. Celeste Simon. Investigating ER stress responses in pancreatic ductal adenocarcinoma under lipid imbalance [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Pancreatic Cancer; 2023 Sep 27-30; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(2 Suppl) nr B054.

PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis

Chronic inflammation confers to the metabolic reprogramming associated with tumorigenesis of colorectal cancer

Altered gut metabolites and metabolic reprogramming involved in the pathogenesis of colitis-associated colorectal cancer and the transition of colon "inflammation to cancer"

Abstract 3155: Metabolic stress induces an intrinsic inflammatory CAF phenotype that regulates stromal architecture in pancreatic cancer

Metabonomic Variation of Exopolysaccharide from Rhizopus Nigricans on AOM/DSS-Induced Colorectal Cancer in Mice

Abstract B054: Investigating ER stress responses in pancreatic ductal adenocarcinoma under lipid imbalance

Targeted Metabolomics Identifies the Cytochrome P450 Monooxygenase Eicosanoid Pathway as a Novel Therapeutic Target of Colon Tumorigenesis

Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma

ER-stress mobilization of death-associated protein kinase-1-dependent xenophagy counteracts mitochondria stress-induced epithelial barrier dysfunction

PIAS3-mediated Feedback Loops Promote Chronic Colitis-Associated Malignant Transformation

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer

Collagen Remodeling Dictates Pancreatic Cancer Bioenergetics and Outcome Through DDR1 Activation or Degradation

Branched-Chain Amino Acid Degradation Pathway was Inactivated in Colorectal Cancer: Results from a Proteomics Study

CALB2 drives pancreatic cancer metastasis through inflammatory reprogramming of the tumor microenvironment

Supplementary Data from Chronic Stress Dampens <i>lactobacillus Johnsonii</i>–Mediated Tumor Suppression to Enhance Colorectal Cancer Progression

Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer

Transcriptome Profiling and Metagenomic Analysis Help to Elucidate Interactions in an Inflammation-Associated Cancer Mouse Model

Inflammation-induced Cellular Changes: Genetic Mutations, Oncogene Impact, and Novel Glycoprotein Biomarkers

Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation

Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome

P073 Enhancing the MFSD2A protein for the treatment of colitis-associated cancer: novel insights for pathogenesis and treatment